Your browser doesn't support javascript.
loading
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Murray, Christopher J L; Ortblad, Katrina F; Guinovart, Caterina; Lim, Stephen S; Wolock, Timothy M; Roberts, D Allen; Dansereau, Emily A; Graetz, Nicholas; Barber, Ryan M; Brown, Jonathan C; Wang, Haidong; Duber, Herbert C; Naghavi, Mohsen; Dicker, Daniel; Dandona, Lalit; Salomon, Joshua A; Heuton, Kyle R; Foreman, Kyle; Phillips, David E; Fleming, Thomas D; Flaxman, Abraham D; Phillips, Bryan K; Johnson, Elizabeth K; Coggeshall, Megan S; Abd-Allah, Foad; Abera, Semaw Ferede; Abraham, Jerry P; Abubakar, Ibrahim; Abu-Raddad, Laith J; Abu-Rmeileh, Niveen Me; Achoki, Tom; Adeyemo, Austine Olufemi; Adou, Arsène Kouablan; Adsuar, José C; Agardh, Emilie Elisabet; Akena, Dickens; Al Kahbouri, Mazin J; Alasfoor, Deena; Albittar, Mohammed I; Alcalá-Cerra, Gabriel; Alegretti, Miguel Angel; Alemu, Zewdie Aderaw; Alfonso-Cristancho, Rafael; Alhabib, Samia; Ali, Raghib; Alla, Francois; Allen, Peter J; Alsharif, Ubai; Alvarez, Elena; Alvis-Guzman, Nelson.
Afiliação
  • Murray CJ; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Ortblad KF; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Guinovart C; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Lim SS; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Wolock TM; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Roberts DA; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Dansereau EA; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Graetz N; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Barber RM; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Brown JC; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Wang H; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Duber HC; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Naghavi M; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Dicker D; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Dandona L; Institute for Health Metrics and Evaluation, Seattle, WA, USA; Public Health Foundation of India, New Delhi, India.
  • Salomon JA; Harvard University, Cambridge, MA, USA.
  • Heuton KR; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Foreman K; Imperial College London, London, UK.
  • Phillips DE; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Fleming TD; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Flaxman AD; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Phillips BK; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Johnson EK; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Coggeshall MS; Institute for Health Metrics and Evaluation, Seattle, WA, USA.
  • Abd-Allah F; Faculty of Medicine, Cairo-University, Cairo, Egypt.
  • Abera SF; College of Health Sciences, School of Public Health, Mekelle, Ethiopia.
  • Abraham JP; University of Texas School of Medicine San Antonio, San Antonio, TX, USA.
  • Abubakar I; University College London, London, UK.
  • Abu-Raddad LJ; Weill Cornell Medical College in Qatar, Doha, Qatar.
  • Abu-Rmeileh NM; Institute of Community and Public Health-Birzeti University, Ramallah, West Bank, Occupied Palestinian Territory.
  • Achoki T; Ministry of Health, Gaborone, Botswana.
  • Adeyemo AO; Evidence For Action (MamaYe), Freetown, Western Area, Sierra Leone.
  • Adou AK; Association Ivoirienne Pour Le Bien Etre Familial, Abidjan, Côte d'Ivoire.
  • Adsuar JC; University of Extremadura, Cáceres, Spain.
  • Agardh EE; Institution of Public Health Sciences, Stockholm, Sweden.
  • Akena D; Makerere University, Kampala, Uganda.
  • Al Kahbouri MJ; Ministry of Health, Muscat, Oman.
  • Alasfoor D; Ministry of Health, Muscat, Oman.
  • Albittar MI; Independent, Damascus, Syria.
  • Alcalá-Cerra G; Grupo de Investigación en Ciencias de la Salud y Neurociencias (CISNEURO), Cartagena de Indias, Colombia.
  • Alegretti MA; Facultad de Medicina, Departamento de Medicina Preventiva y Social, Universidad de la República, Montevideo, Uruguay.
  • Alemu ZA; Debre Markos University, Debre Markos, Ethiopia.
  • Alfonso-Cristancho R; University of Washington, Seattle, WA, USA.
  • Alhabib S; National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Ali R; University of Oxford, Oxford, UK.
  • Alla F; School of Public Health, University of Lorraine, Nancy, France.
  • Allen PJ; Ministry of Health, Belmopan, Cayo, Belize.
  • Alsharif U; Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Alvarez E; Government, Madrid, Spain.
  • Alvis-Guzman N; Universidad de Cartagena, Cartagena de Indias, Colombia.
Lancet ; 384(9947): 1005-70, 2014 Sep 13.
Article em En | MEDLINE | ID: mdl-25059949
BACKGROUND: The Millennium Declaration in 2000 brought special global attention to HIV, tuberculosis, and malaria through the formulation of Millennium Development Goal (MDG) 6. The Global Burden of Disease 2013 study provides a consistent and comprehensive approach to disease estimation for between 1990 and 2013, and an opportunity to assess whether accelerated progress has occured since the Millennium Declaration. METHODS: To estimate incidence and mortality for HIV, we used the UNAIDS Spectrum model appropriately modified based on a systematic review of available studies of mortality with and without antiretroviral therapy (ART). For concentrated epidemics, we calibrated Spectrum models to fit vital registration data corrected for misclassification of HIV deaths. In generalised epidemics, we minimised a loss function to select epidemic curves most consistent with prevalence data and demographic data for all-cause mortality. We analysed counterfactual scenarios for HIV to assess years of life saved through prevention of mother-to-child transmission (PMTCT) and ART. For tuberculosis, we analysed vital registration and verbal autopsy data to estimate mortality using cause of death ensemble modelling. We analysed data for corrected case-notifications, expert opinions on the case-detection rate, prevalence surveys, and estimated cause-specific mortality using Bayesian meta-regression to generate consistent trends in all parameters. We analysed malaria mortality and incidence using an updated cause of death database, a systematic analysis of verbal autopsy validation studies for malaria, and recent studies (2010-13) of incidence, drug resistance, and coverage of insecticide-treated bednets. FINDINGS: Globally in 2013, there were 1·8 million new HIV infections (95% uncertainty interval 1·7 million to 2·1 million), 29·2 million prevalent HIV cases (28·1 to 31·7), and 1·3 million HIV deaths (1·3 to 1·5). At the peak of the epidemic in 2005, HIV caused 1·7 million deaths (1·6 million to 1·9 million). Concentrated epidemics in Latin America and eastern Europe are substantially smaller than previously estimated. Through interventions including PMTCT and ART, 19·1 million life-years (16·6 million to 21·5 million) have been saved, 70·3% (65·4 to 76·1) in developing countries. From 2000 to 2011, the ratio of development assistance for health for HIV to years of life saved through intervention was US$4498 in developing countries. Including in HIV-positive individuals, all-form tuberculosis incidence was 7·5 million (7·4 million to 7·7 million), prevalence was 11·9 million (11·6 million to 12·2 million), and number of deaths was 1·4 million (1·3 million to 1·5 million) in 2013. In the same year and in only individuals who were HIV-negative, all-form tuberculosis incidence was 7·1 million (6·9 million to 7·3 million), prevalence was 11·2 million (10·8 million to 11·6 million), and number of deaths was 1·3 million (1·2 million to 1·4 million). Annualised rates of change (ARC) for incidence, prevalence, and death became negative after 2000. Tuberculosis in HIV-negative individuals disproportionately occurs in men and boys (versus women and girls); 64·0% of cases (63·6 to 64·3) and 64·7% of deaths (60·8 to 70·3). Globally, malaria cases and deaths grew rapidly from 1990 reaching a peak of 232 million cases (143 million to 387 million) in 2003 and 1·2 million deaths (1·1 million to 1·4 million) in 2004. Since 2004, child deaths from malaria in sub-Saharan Africa have decreased by 31·5% (15·7 to 44·1). Outside of Africa, malaria mortality has been steadily decreasing since 1990. INTERPRETATION: Our estimates of the number of people living with HIV are 18·7% smaller than UNAIDS's estimates in 2012. The number of people living with malaria is larger than estimated by WHO. The number of people living with HIV, tuberculosis, or malaria have all decreased since 2000. At the global level, upward trends for malaria and HIV deaths have been reversed and declines in tuberculosis deaths have accelerated. 101 countries (74 of which are developing) still have increasing HIV incidence. Substantial progress since the Millennium Declaration is an encouraging sign of the effect of global action. FUNDING: Bill & Melinda Gates Foundation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Saúde Global / Malária Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Infecções por HIV / Saúde Global / Malária Idioma: En Ano de publicação: 2014 Tipo de documento: Article